Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Oncotarget
|
June 5, 2018
Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy
Guillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, et al.
Cancers
|
April 30, 2021
Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study
Guillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, et al.
Cancer Research
|
December 8, 2017
Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy
Sylvain Simon, Virginie Vignard, Emilie Varey, et al.
European Journal of Dermatology : EJD
|
August 8, 2019
Efficacy and safety of nivolumab in metastatic melanoma: real-world practice
Solène Bocquet-Tremoureux, Emeric Scharbarg, Jean-Michel Nguyen, et al.
Acta Dermato-Venereologica
|
January 13, 2018
Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma
Edouard Chasseuil, Mélanie Saint-Jean, Hannah Chasseuil, et al.
Transplantation
|
May 21, 2020
Preclinical Assessment of Autologous Tolerogenic Dendritic Cells From End-stage Renal Disease Patients
Laurence Bouchet-Delbos, Amandine Even, Emilie Varey, et al.
Cancers
|
July 16, 2020
Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic <i>BRAF</i> or <i>NRAS</i>-Mutated Melanoma Patients
Guillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, et al.
JMIR Medical Informatics
|
June 25, 2024
Implementing a Biomedical Data Warehouse From Blueprint to Bedside in a Regional French University Hospital Setting: Unveiling Processes, Overcoming Challenges, and Extracting Clinical Insight
Matilde Karakachoff, Thomas Goronflot, Sandrine Coudol, et al.
Experimental Dermatology
|
May 20, 2016
Clinical significance of BRAF mutation status in circulating tumor DNA of metastatic melanoma patients at baseline
Anne C Knol, Audrey Vallée, Guillaume Herbreteau, et al.
European Journal of Dermatology : EJD
|
August 21, 2020
Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological data from the RIC-Mel database
Stephane Dalle, Emilie Varey, Jean-Michel Nguyen, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Oncotarget
|
June 5, 2018
Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy
Guillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, et al.
Cancers
|
April 30, 2021
Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study
Guillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, et al.
Cancer Research
|
December 8, 2017
Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy
Sylvain Simon, Virginie Vignard, Emilie Varey, et al.
European Journal of Dermatology : EJD
|
August 8, 2019
Efficacy and safety of nivolumab in metastatic melanoma: real-world practice
Solène Bocquet-Tremoureux, Emeric Scharbarg, Jean-Michel Nguyen, et al.
Acta Dermato-Venereologica
|
January 13, 2018
Blood Predictive Biomarkers for Nivolumab in Advanced Melanoma
Edouard Chasseuil, Mélanie Saint-Jean, Hannah Chasseuil, et al.
Transplantation
|
May 21, 2020
Preclinical Assessment of Autologous Tolerogenic Dendritic Cells From End-stage Renal Disease Patients
Laurence Bouchet-Delbos, Amandine Even, Emilie Varey, et al.
Cancers
|
July 16, 2020
Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic <i>BRAF</i> or <i>NRAS</i>-Mutated Melanoma Patients
Guillaume Herbreteau, Audrey Vallée, Anne-Chantal Knol, et al.
JMIR Medical Informatics
|
June 25, 2024
Implementing a Biomedical Data Warehouse From Blueprint to Bedside in a Regional French University Hospital Setting: Unveiling Processes, Overcoming Challenges, and Extracting Clinical Insight
Matilde Karakachoff, Thomas Goronflot, Sandrine Coudol, et al.
Experimental Dermatology
|
May 20, 2016
Clinical significance of BRAF mutation status in circulating tumor DNA of metastatic melanoma patients at baseline
Anne C Knol, Audrey Vallée, Guillaume Herbreteau, et al.
European Journal of Dermatology : EJD
|
August 21, 2020
Management of adjuvant settings for Stage III melanoma patients in France prior to checkpoint inhibitors: epidemiological data from the RIC-Mel database
Stephane Dalle, Emilie Varey, Jean-Michel Nguyen, et al.
Page
of 3